Stopped clinical trials give evidence for the value of genetics
A new analysis of clinical trials that were stopped early generates insights on the role of genetics in drug development and provides a new resource for researchers aiming to improve success rates of clinical trials.
Gespeichert in:
Veröffentlicht in: | Nature genetics 2024-09, Vol.56 (9), p.1766-1767 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1767 |
---|---|
container_issue | 9 |
container_start_page | 1766 |
container_title | Nature genetics |
container_volume | 56 |
creator | King, Emily |
description | A new analysis of clinical trials that were stopped early generates insights on the role of genetics in drug development and provides a new resource for researchers aiming to improve success rates of clinical trials. |
doi_str_mv | 10.1038/s41588-024-01834-3 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3086061916</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3086061916</sourcerecordid><originalsourceid>FETCH-LOGICAL-c256t-91b8901f355094c8046aa2fafb2e7cd54611382e91d3fb4f7c8b84dd257ea4193</originalsourceid><addsrcrecordid>eNp9kMtKxTAQhoMo3l_AhQTcuKnOJGmbrkTEGwgu1HVI08mx0tMek_aAb2_0eAEXrjKQb_6Z-Rg7QDhBkPo0Ksy1zkCoDFBLlck1to25KjIsUa-nGgrMFMhii-3E-AKASoHeZFuygjIXUG2zs4dxWCyo4a5r-9bZjo-htV3ks3ZJnJZtQ70j7ofAx2fiS9tNxAfPZ9TT2Lq4xzZ8wmn_691lT1eXjxc32d399e3F-V3mRF6MWYW1rgC9zHOolNOgCmuFt74WVLom7YwotaAKG-lr5Uuna62aRuQlWYWV3GXHq9xFGF4niqOZt9FR19mehikaCbpI11ZYJPToD_oyTKFP2xmJCCAFlJgosaJcGGIM5M0itHMb3gyC-dBrVnpN0ms-9RqZmg6_oqd6Ts1Py7fPBMgVENNXP6PwO_uf2HfD2YN3</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3110032071</pqid></control><display><type>article</type><title>Stopped clinical trials give evidence for the value of genetics</title><source>Nature</source><source>Alma/SFX Local Collection</source><creator>King, Emily</creator><creatorcontrib>King, Emily</creatorcontrib><description>A new analysis of clinical trials that were stopped early generates insights on the role of genetics in drug development and provides a new resource for researchers aiming to improve success rates of clinical trials.</description><identifier>ISSN: 1061-4036</identifier><identifier>ISSN: 1546-1718</identifier><identifier>EISSN: 1546-1718</identifier><identifier>DOI: 10.1038/s41588-024-01834-3</identifier><identifier>PMID: 39075209</identifier><language>eng</language><publisher>New York: Nature Publishing Group US</publisher><subject>631/114/2164 ; 631/154 ; 631/208 ; Agriculture ; Animal Genetics and Genomics ; Biomedical and Life Sciences ; Biomedicine ; Cancer Research ; Clinical trials ; Datasets ; Disease ; Drug development ; Gene Function ; Genetics ; Genomics ; Human Genetics ; Hypotheses ; Mutation ; Natural language processing ; News & Views ; news-and-views ; Pharmaceutical industry ; Proteins ; Success</subject><ispartof>Nature genetics, 2024-09, Vol.56 (9), p.1766-1767</ispartof><rights>Springer Nature America, Inc. 2024</rights><rights>Copyright Nature Publishing Group Sep 2024</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c256t-91b8901f355094c8046aa2fafb2e7cd54611382e91d3fb4f7c8b84dd257ea4193</cites><orcidid>0000-0003-1877-8673</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39075209$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>King, Emily</creatorcontrib><title>Stopped clinical trials give evidence for the value of genetics</title><title>Nature genetics</title><addtitle>Nat Genet</addtitle><addtitle>Nat Genet</addtitle><description>A new analysis of clinical trials that were stopped early generates insights on the role of genetics in drug development and provides a new resource for researchers aiming to improve success rates of clinical trials.</description><subject>631/114/2164</subject><subject>631/154</subject><subject>631/208</subject><subject>Agriculture</subject><subject>Animal Genetics and Genomics</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer Research</subject><subject>Clinical trials</subject><subject>Datasets</subject><subject>Disease</subject><subject>Drug development</subject><subject>Gene Function</subject><subject>Genetics</subject><subject>Genomics</subject><subject>Human Genetics</subject><subject>Hypotheses</subject><subject>Mutation</subject><subject>Natural language processing</subject><subject>News & Views</subject><subject>news-and-views</subject><subject>Pharmaceutical industry</subject><subject>Proteins</subject><subject>Success</subject><issn>1061-4036</issn><issn>1546-1718</issn><issn>1546-1718</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kMtKxTAQhoMo3l_AhQTcuKnOJGmbrkTEGwgu1HVI08mx0tMek_aAb2_0eAEXrjKQb_6Z-Rg7QDhBkPo0Ksy1zkCoDFBLlck1to25KjIsUa-nGgrMFMhii-3E-AKASoHeZFuygjIXUG2zs4dxWCyo4a5r-9bZjo-htV3ks3ZJnJZtQ70j7ofAx2fiS9tNxAfPZ9TT2Lq4xzZ8wmn_691lT1eXjxc32d399e3F-V3mRF6MWYW1rgC9zHOolNOgCmuFt74WVLom7YwotaAKG-lr5Uuna62aRuQlWYWV3GXHq9xFGF4niqOZt9FR19mehikaCbpI11ZYJPToD_oyTKFP2xmJCCAFlJgosaJcGGIM5M0itHMb3gyC-dBrVnpN0ms-9RqZmg6_oqd6Ts1Py7fPBMgVENNXP6PwO_uf2HfD2YN3</recordid><startdate>20240901</startdate><enddate>20240901</enddate><creator>King, Emily</creator><general>Nature Publishing Group US</general><general>Nature Publishing Group</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7SS</scope><scope>7T7</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1877-8673</orcidid></search><sort><creationdate>20240901</creationdate><title>Stopped clinical trials give evidence for the value of genetics</title><author>King, Emily</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c256t-91b8901f355094c8046aa2fafb2e7cd54611382e91d3fb4f7c8b84dd257ea4193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>631/114/2164</topic><topic>631/154</topic><topic>631/208</topic><topic>Agriculture</topic><topic>Animal Genetics and Genomics</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer Research</topic><topic>Clinical trials</topic><topic>Datasets</topic><topic>Disease</topic><topic>Drug development</topic><topic>Gene Function</topic><topic>Genetics</topic><topic>Genomics</topic><topic>Human Genetics</topic><topic>Hypotheses</topic><topic>Mutation</topic><topic>Natural language processing</topic><topic>News & Views</topic><topic>news-and-views</topic><topic>Pharmaceutical industry</topic><topic>Proteins</topic><topic>Success</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>King, Emily</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Nature genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>King, Emily</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Stopped clinical trials give evidence for the value of genetics</atitle><jtitle>Nature genetics</jtitle><stitle>Nat Genet</stitle><addtitle>Nat Genet</addtitle><date>2024-09-01</date><risdate>2024</risdate><volume>56</volume><issue>9</issue><spage>1766</spage><epage>1767</epage><pages>1766-1767</pages><issn>1061-4036</issn><issn>1546-1718</issn><eissn>1546-1718</eissn><abstract>A new analysis of clinical trials that were stopped early generates insights on the role of genetics in drug development and provides a new resource for researchers aiming to improve success rates of clinical trials.</abstract><cop>New York</cop><pub>Nature Publishing Group US</pub><pmid>39075209</pmid><doi>10.1038/s41588-024-01834-3</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0003-1877-8673</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1061-4036 |
ispartof | Nature genetics, 2024-09, Vol.56 (9), p.1766-1767 |
issn | 1061-4036 1546-1718 1546-1718 |
language | eng |
recordid | cdi_proquest_miscellaneous_3086061916 |
source | Nature; Alma/SFX Local Collection |
subjects | 631/114/2164 631/154 631/208 Agriculture Animal Genetics and Genomics Biomedical and Life Sciences Biomedicine Cancer Research Clinical trials Datasets Disease Drug development Gene Function Genetics Genomics Human Genetics Hypotheses Mutation Natural language processing News & Views news-and-views Pharmaceutical industry Proteins Success |
title | Stopped clinical trials give evidence for the value of genetics |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T08%3A55%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Stopped%20clinical%20trials%20give%20evidence%20for%20the%20value%20of%20genetics&rft.jtitle=Nature%20genetics&rft.au=King,%20Emily&rft.date=2024-09-01&rft.volume=56&rft.issue=9&rft.spage=1766&rft.epage=1767&rft.pages=1766-1767&rft.issn=1061-4036&rft.eissn=1546-1718&rft_id=info:doi/10.1038/s41588-024-01834-3&rft_dat=%3Cproquest_cross%3E3086061916%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3110032071&rft_id=info:pmid/39075209&rfr_iscdi=true |